Search Login Register
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
(AMPA)
Summary
Description:
An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Also Known As:
AMPA; alpha Amino 3 hydroxy 5 methyl 4 isoxazolepropionic Acid; AMPA, (+-)-Isomer; AMPA, (R)-Isomer; AMPA, (R)-Isomer, Monohydrobromide Show All >>
Networked: 920
relevant articles (50 outcomes,
99 trials/studies)
for this Bio-Agent
Key Diseases for which alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid is
Relevant
-
Seizures (Seizure)
:
14 outcomes 16 studies in 165 results
-
Ischemia
:
5 outcomes 5 studies in 68 results
-
Parkinson Disease (Parkinson's Disease)
:
4 outcomes 1 study in 15 results
-
Schizophrenia (Dementia Praecox)
:
3 outcomes 7 studies in 44 results
-
Alzheimer Disease (Alzheimer's Disease)
:
3 outcomes 5 studies in 28 results
Show All >>
Drugs Related to alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
-
N-Methylaspartate (NMDA)
-
Kainic Acid (Kainate)
-
2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)
-
Kainic Acid Receptors (Kainate Receptor)
-
Glutamate Receptors (Glutamate Receptor)
-
alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
-
topiramate (Topamax)
-
AMPA Receptors (AMPA Receptor)
-
GYKI 52466
-
Glutamic Acid (Glutamate)
Show All >>
Therapies Related to alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
-
Therapeutics
-
Intra-Articular Injections
-
Spinal Injections
-
Injections
-
Resuscitation
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.